S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
NASDAQ:APVO

Aptevo Therapeutics Insider Trades

$7.93
-2.03 (-20.38%)
(As of 12/1/2021 04:00 PM ET)
Add
Compare
Today's Range
$7.90
$9.73
50-Day Range
$6.48
$17.49
52-Week Range
$6.38
$51.75
Volume
1.82 million shs
Average Volume
962,056 shs
Market Capitalization
$38.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
6.74

Aptevo Therapeutics (NASDAQ:APVO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.88%

Number Of
Insiders Buying
(Last 12 Months)
0

Number Of
Insiders Selling
(Last 12 Months)
1

Amount Of
Insider Selling
(Last 12 Months)
$4.88 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get APVO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aptevo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Aptevo Therapeutics (NASDAQ APVO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Kevin C TangMajor ShareholderSell255,331$7.03$1,794,976.93  
11/18/2021Kevin C TangMajor ShareholderSell369,533$8.34$3,081,905.22  
11/6/2020Kevin C TangMajor ShareholderBuy174,277$22.73$3,961,316.21  
11/4/2020Kevin C TangMajor ShareholderBuy636,675$14.35$9,136,286.25  
8/16/2019Randy Joe MadduxCMOBuy25,000$0.76$19,000.0075,000  
8/12/2019Fuad El-HibriDirectorBuy100,000$0.76$76,000.001,124,536  
7/29/2019Fuad El-HibriDirectorBuy55,015$0.83$45,662.451,024,536  
7/22/2019Fuad El-HibriDirectorBuy30,000$0.89$26,700.00959,521  
7/18/2019Fuad El-HibriDirectorBuy14,404$0.87$12,531.48903,061  
7/16/2019Fuad El-HibriDirectorBuy11,375$0.85$9,668.75869,521  
7/10/2019Fuad El-HibriDirectorBuy18,919$0.85$16,081.15843,455  
6/25/2019Daniel Abdun-NabiDirectorBuy16,667$0.90$15,000.30109,351  
6/14/2019Marvin L WhiteCEOBuy50,000$0.88$44,000.00293,603  
6/10/2019Barbara Lopez KunzDirectorBuy10,000$0.85$8,500.0010,000  
6/7/2019Zsolt HarsanyiDirectorBuy50,000$0.78$39,000.0050,000  
5/31/2019Randy Joe MadduxVPBuy20,000$0.73$14,600.0050,000  
5/21/2019Grady Grant IIIDirectorBuy10,000$0.80$8,000.0010,000  
5/20/2019Marvin L WhiteCEOBuy30,000$0.81$24,300.00243,603  
5/14/2019Marvin L WhiteInsiderBuy10,000$0.78$7,800.00213,603  
12/6/2018Randy Joe MadduxSVPBuy5,000$2.37$11,850.0030,000  
12/4/2018Marvin L WhiteInsiderBuy10,000$2.38$23,800.00203,603  
3/19/2018Marvin L WhiteInsiderSell100,000$2.93$293,000.00  
11/15/2017Randy Joe MadduxVPBuy25,000$2.76$69,000.0025,000  
(Data available from 1/1/2013 forward)












Aptevo Therapeutics (NASDAQ:APVO) Insider Trade Frequently Asked Questions

Who is on Aptevo Therapeutics's Insider Roster?

The list of insiders at Aptevo Therapeutics includes Barbara Lopez Kunz, Daniel Abdun-Nabi, Fuad El-Hibri, Grady Grant III, Kevin C Tang, Marvin L White, Randy Joe Maddux, and Zsolt Harsanyi.Learn more on APVO's insiders

What percentage of Aptevo Therapeutics stock is owned by insiders?

10.88% of Aptevo Therapeutics stock is owned by insiders. Learn more on APVO's insider holdings

Which Aptevo Therapeutics insiders have been buying company stock?

The following insider purchased Aptevo Therapeutics stock in the last 24 months: Kevin C Tang ($13,097,602.46).

How much insider buying is happening at Aptevo Therapeutics?

Insiders have purchased a total of 810,952 Aptevo Therapeutics shares in the last 24 months for a total of $13,097,602.46 bought.

Which Aptevo Therapeutics insiders have been selling company stock?

The following insider sold Aptevo Therapeutics stock in the last 24 months: Kevin C Tang ($4,876,882.15).

How much insider selling is happening at Aptevo Therapeutics?

Insiders have sold a total of 624,864 Aptevo Therapeutics shares in the last 24 months for a total of $4,876,882.15 sold.

This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.